Human Responses in Public Health Emergencies for Infectious Disease Control: An Overview of Controlled Topologies for Biomedical Applications

Naseri, Kamal; Aliashrafzadeh, Hasan; Otadi, Mahmood; Ebrahimzadeh, Farnoosh; Badfar, Homayoun; Alipourfard, Iraj

doi:10.1155/2022/6324462

Cited by 2 publications

(2 citation statements)

References 129 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Governments and scientists have made many efforts to prevent, control and treat COVID-19 and have found some suitable control methods including mRNA vaccines (Naseri et al, 2022). Previous studies have shown that angiotensin-converting enzyme II (ACE2) is the main membrane receptor for SARS-CoV-2 entry into host cells (Pandey et al, 2021).…”

Section: Introductionmentioning

confidence: 99%

Respiratory RNA viruses: Molecular mechanisms of viral replication and pathogenicity

2024

Frontiers Research Topics

View full text Add to dashboard Cite

Frontiers is more than just an open access publisher of scholarly articles: it is a pioneering approach to the world of academia, radically improving the way scholarly research is managed. The grand vision of Frontiers is a world where all people have an equal opportunity to seek, share and generate knowledge. Frontiers provides immediate and permanent online open access to all its publications, but this alone is not enough to realize our grand goals. Frontiers journal seriesThe Frontiers journal series is a multi-tier and interdisciplinary set of openaccess, online journals, promising a paradigm shift from the current review, selection and dissemination processes in academic publishing. All Frontiers journals are driven by researchers for researchers; therefore, they constitute a service to the scholarly community. At the same time, the Frontiers journal series operates on a revolutionary invention, the tiered publishing system, initially addressing specific communities of scholars, and gradually climbing up to broader public understanding, thus serving the interests of the lay society, too. Dedication to qualityEach Frontiers article is a landmark of the highest quality, thanks to genuinely collaborative interactions between authors and review editors, who include some of the world's best academicians. Research must be certified by peers before entering a stream of knowledge that may eventually reach the public -and shape society; therefore, Frontiers only applies the most rigorous and unbiased reviews. Frontiers revolutionizes research publishing by freely delivering the most outstanding research, evaluated with no bias from both the academic and social point of view. By applying the most advanced information technologies, Frontiers is catapulting scholarly publishing into a new generation. What are Frontiers Research Topics?Frontiers Research Topics are very popular trademarks of the Frontiers journals series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area.

show abstract

Section: Introductionmentioning

confidence: 99%

Respiratory RNA viruses: Molecular mechanisms of viral replication and pathogenicity

2024

Frontiers Research Topics

View full text Add to dashboard Cite

show abstract

“…Governments and scientists have made many efforts to prevent, control and treat COVID-19 and have found some suitable control methods including mRNA vaccines ( Naseri et al, 2022 ). Previous studies have shown that angiotensin-converting enzyme II (ACE2) is the main membrane receptor for SARS-CoV-2 entry into host cells ( Pandey et al, 2021 ).…”

Section: Introductionmentioning

confidence: 99%

Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future

et al. 2023

View full text Add to dashboard Cite

Since the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its resultant pneumonia in December 2019, the cumulative number of infected people worldwide has exceeded 670 million, with over 6.8 million deaths. Despite the marketing of multiple series of vaccines and the implementation of strict prevention and control measures in many countries, the spread and prevalence of SARS-CoV-2 have not been completely and effectively controlled. The latest research shows that in addition to angiotensin converting enzyme II (ACE2), dozens of protein molecules, including AXL, can act as host receptors for SARS-CoV-2 infecting human cells, and virus mutation and immune evasion never seem to stop. To sum up, this review summarizes and organizes the latest relevant literature, comprehensively reviews the genome characteristics of SARS-CoV-2 as well as receptor-based pathogenesis (including ACE2 and other new receptors), mutation and immune evasion, vaccine development and other aspects, and proposes a series of prevention and treatment opinions. It is expected to provide a theoretical basis for an in-depth understanding of the pathogenic mechanism of SARS-CoV-2 along with a research basis and new ideas for the diagnosis and classification, of COVID-19-related disease and for drug and vaccine research and development.

show abstract

Human Responses in Public Health Emergencies for Infectious Disease Control: An Overview of Controlled Topologies for Biomedical Applications

Cited by 2 publications

References 129 publications

Respiratory RNA viruses: Molecular mechanisms of viral replication and pathogenicity

Respiratory RNA viruses: Molecular mechanisms of viral replication and pathogenicity

Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future

Contact Info

Product

Resources

About